This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
So the top questions that go beyond the usual duediligence that companies must ask when evaluating generative AI vendors have to with training data, copyright, added value, and model independence. Data privacy, security, and compliance For Rich Products, data protection, responsible AI, and trustworthy AI are critical. “But
Clinical Pipelines and Drug Developments – Assessing the pipeline of pharmaceutical and biotechnology companies by analyzing clinical trials to gauge the potential success of new drugs or therapies in development.
These intangible factors indicate that even the most exhaustive duediligence processes can still leave gaps in the M&A research process. Comprehensive DueDiligence Thorough duediligence on a target company is undeniably the cornerstone of successful M&A.
Venture capital investors can optimize their primary investment research by leveraging AlphaSense to gain quality expert insights , an integrated workflow , faster time to insight , and more comprehensive duediligence. Want to learn about how AlphaSense is empowering venture capital firms to accelerate their research efforts?
Without an official system to check an organization’s commitment to its ESG policies, many shareholders and investors are doing their duediligence through fact-checking. timber, natural pharmaceuticals) and services (i.e., In fact, biodiversity attrition can also severely hinder a company’s bottom line.
One AlphaSense customer has saved tens of thousands of dollars by using our AI-search technology to optimize their research at various pharmaceutical companies. Expert Networks are Primarily for Market Research Another misconception about expert networks is that they can only be used for market research.
Although, they’re trying to make TPU as a more open framework.” – Former Head of Engineering, Google | Expert Transcript When a pharmaceutical company launches a new drug, how do you know if the benefits to patients outweigh the side effects and costs? If you’re going to force me into TPU, that’s like locking me in.
Massive Data Analysis It’s clear that the pharmaceutical industry is increasingly in need of handling and interpreting expansive datasets efficiently and accurately. In the realm of supplier relations, AI applications provide transparency and foster collaboration between pharmaceutical companies and their partners.
This emerging trend is allowing pharmaceutical companies—large and small—to distinguish themselves among competitors and investors as they pioneer advancements fueled by AI. M&A will serve as an avenue for pharmaceutical companies and start-ups to continue making significant advancements in their respective fields.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content